CleveMed’s in the news again: in one of the top 10 most read Sleep Review articles in September 2021, CleveMed was cited as a long term advocate and innovator in the area of PAP follow-up evaluation.


When should a treated OSA patient have a repeat PSG or HSAT? The American Academy of Sleep Medicine releases its first statement to guide clinicians.

For the first time, the American Academy of Sleep Medicine (AASM) has issued guidance for the appropriate use of follow-up polysomnography (PSG) or home sleep apnea tests (HSATs) on patients undergoing treatment for obstructive sleep apnea (OSA). Because OSA is a chronic disorder with many associated health risks, its successful long-term management is vital to patient health and sleep-related quality of life.

Although previously issued guidelines addressed the initial indications for sleep apnea testing for diagnostic purposes, there has not been established guidance for clinicians about if or when follow-up testing should be performed in patients with a diagnosis of OSA.

For many, this is welcome and long-awaited news.

“We are so excited to learn that the American Academy of Sleep Medicine expanded the utility of home sleep apnea testing to include longitudinal therapy evaluation,” says Hani Kayyali, president and CEO of CleveMed, a manufacturer of sleep monitoring technologies. “We are strong believers that, similar to other chronic conditions, follow-up testing on OSA patients is needed to improve long-term care.” CleveMed holds multiple patents covering technologies for longitudinal positive airway pressure therapy evaluation…